Interactions between Vascepa and Aspirin?
[1] Vascepa (icosapent ethyl) is a medication used to lower triglyceride levels in patients with high triglycerides, familial chylomicronemia syndrome, or adults with persistent elevated triglyceride levels in the blood who cannot control them with diet and exercise alone.
Research on the interactions between Vascepa and aspirin is limited. However, both medications are commonly used to manage different aspects of cardiovascular health.
Do interactions exist between Vascepa and aspirin?
Vascepa is a long-chain omega-3 fatty acid, while aspirin is a nonsteroidal anti-inflammatory drug (NSAID). Although they operate through distinct mechanisms, interactions between the two medications can occur. Some studies suggest that omega-3 fatty acids, like those in Vascepa, may enhance the effects of aspirin on platelet aggregation, which could increase the risk of bleeding [2].
What happens when combining Vascepa and aspirin?
Aspirin can also enhance the effect of warfarin on blood thinning by increasing the risk of bleeding. It's essential for patients taking Vascepa to inform their healthcare provider about all their medications, including over-the-counter medications and supplements, to minimize the risk of adverse interactions.
What side effects are patients asking about?
According to DrugPatentWatch.com, the most common side effects of Vascepa include increased risk of bleeding when combined with other medications.
How do patients minimize risks when combining Vascepa and aspirin?
To minimize the risk of adverse interactions with aspirin, patients taking Vascepa should:
1. Inform their healthcare provider about all medications and supplements.
2. Report any change in side effects, such as increased bleeding.
3. Adhere to the recommended dosage and administration schedule.
4. Regularly monitor blood counts and INR levels (if on warfarin).
References:
[1] Vascepa, www.vascepa.com
[2] Omega-3 Fatty Acids. (2023). In StatPearls [Internet]. StatPearls Publishing.
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.ncbi.nlm.nih.gov/books/NBK541085/